Sale25 Sept 2026, 01:16 pm
Molbio Diagnostics: India Business Excellence Fund III Sells 2.60% Stake
AI Summary
Molbio Diagnostics Ltd has received a revised disclosure from India Business Excellence Fund III regarding the sale of equity shares. The fund sold 30,00,000 equity shares, representing 2.60% of the total share capital, on September 23, 2026. This sale reduces their holding from 11.52% to 8.92%. The transaction was conducted via the open market. This revised disclosure supersedes a previous one due to a clerical error.
Key Highlights
- India Business Excellence Fund III sold 30,00,000 shares.
- The sale represents a 2.60% stake in Molbio Diagnostics.
- Holding reduced from 11.52% to 8.92% post-transaction.
- Transaction occurred on September 23, 2026, via open market.
- Revised disclosure submitted due to clerical error.
Price Impact
More from MOLBIO